Abstract:Purpose/Objective: MR and CT fusion with CT-based dose calculation has become a routine procedure for IMRT treatment planning. The purpose of this study is to investigate the clinical implementation of MRI-based treatment planning (MRI simulation) for prostate cancer. MRI simulation retains the superior soft-tissue contrast for image segmentation while eliminates the potential error in image fusion due to variations in patient position between CT and MRI and uncertainties in localizing the same structures between the two data sets. Furthermore, MRI simulation will avoid redundant CT imaging sessions, which in turn will avoid unnecessary radiation exposure to the patient, reduce treatment cost, and save patient, staff and machine time. Materials/Methods: A 0.23 T open MR scanner (Philips Medical Systems, Cleveland, OH) was used for this study. Patients were scanned in a supine position in an alpha cradle with knee support and foot holder. One axial reference T2-weighted MR image was obtained with three donut-shaped fiducials on the skin to mark the approximate center of the prostate. A saggittal image was obtained through the center of the prostate as depicted on the axial image. The fiducials were then adjusted to mark the isocenter using a set of trackable lasers. The MRI data consisted of 48 slices (3-mm thickness) covering the whole pelvis. Skin marks were then made for daily treatment setup. The MR images were post processed using a gradient distortion correction (GDC) program provided by the vendor. The prostate and other critical structures were contoured and then transferred together with the MRI data to a commercial inverse planning system. Twenty IMRT plans were made using both unit density MRI and CT with the same beam angles, dose constraints and optimization parameters and the resulting plans were compared in terms of isodose distributions and dose volume histograms (DVH). A hybrid plan is generated for both the CT-based plan and the MR-based plan using the leaf sequences and associated MU designed for the corresponding patient plans. The physical phantom is then irradiated using the same leaf sequences to verify the dosimetry accuracy of the treatment plans. Results: Donut shaped fiducial markers worked well in isocenter localization since the center of the fiducial marker could be clearly determined in one MR slice. The CORVUS treatment planning system (version 5.0) allowed dose calculation on both CT and MRI. Small discrepancies (3–5%) in structure volumes were observed between CT and MR due to image resolution and algorithmic differences in volume determination. Small (∼1.5 cm) differences were also found in external contours between CT and MRI due to residual MRI distortion, which resulted in some differences in intensity maps. However, the final dose distributions were equally acceptable based on our clinical criteria (e.g., V95 = 100% of the prescribed target dose, R40 < 35%, R50 < 17% of the rectal volume, etc.). The absolute dose agreed within 3% between measured dose and dose predicted by the planning system in the physical phantom. The BAT ultrasound system was used for daily target localization and a MRI based DRR was used as a reference to assist setup verification. Conclusions: Our results showed that MRI-based simulation meets the accuracy requirement for patient setup, image segmentation, dose calculation and treatment verification for prostate treatment. Commissioning and quality assurance procedures have been developed for MRI simulation and are being implemented clinically for prostate IMRT at this institution.

TH-C-201B-04: Methods to Account for Imaging Doses from Diagnostic MDCT or Kilovoltage CBCT in Prostate Treatment Planning: Monte Carlo Studies Using Scanner Models and Patient-Specific Anatomy

Monte Carlo Calculation of Imaging Doses from Diagnostic Multidetector Ct and Kilovoltage Cone-Beam Ct As Part of Prostate Cancer Treatment Plans

Volumetric and Dosimetric Variations in Radiation Treatment Planning Using CT Images Based on Different Reconstructed Field-of-view

Evaluation Of The Dosimetric Impact Of Interfractional Anatomical Variations On Prostate Proton Therapy Using Daily In-Room Ct Images

SU-GG-I-63: Calculations of Organ Doses From Cone-Beam CT IGRT Procedures Using a Suite of Patient Phantoms

Optimizing CT Acquisition for Prostate Cancer Radiation Treatment Planning and Delivery

TH-D-BRC-08: Monte Carlo Based KV CBCT Modeling and Dose Calculations Involving Anatomical Phantom

Impact Of Interfractional Motion On Hypofractionated Pencil Beam Scanning Proton Therapy And Vmat Delivery For Prostate Cancer

Assessment of Patient Organ Doses and Effective Doses Using the VIP-Man Adult Male Phantom for Selected Cone-Beam CT Imaging Procedures During Image Guided Radiation Therapy.

Dosimetric Effects of Air Cavities for MRI-Guided Online Adaptive Radiation Therapy (MRgART) of Prostate Bed after Radical Prostatectomy

Dose Calculation Deviations Induced by Fractional Image-Guided-couch-shifts for Varian Halcyon MV Cone Beam CT

SU-GG-T-347: Methods to Calculate Organ Doses Due to Scattered Radiation From External Beam Radiation Treatment Using Various Patient Phantoms and Monte Carlo Simulations

Use of Kilovoltage X-ray Volume Imaging in Patient Dose Calculation for Head-and-neck and Partial Brain Radiation Therapy.

Kilo-Voltage Imaging Doses To Organs-At-Risk In Cbct-Guided Breast Radiation Therapy

Imaging Dose and Risk of Varian Thoracic Cone Beam CT to the ICRP Computational Reference Phantom

Image Registration and Target Volume Margins in Cone-Beam Computed Tomography-Guided Intensity-Modulated Radiotherapy for Prostate Cancer

Clinical implementation of MRI simulation for IMRT of prostate cancer

Evaluation of cumulative dose distributions from external beam radiation therapy using CT‐to‐CBCT deformable image registration (DIR) for cervical cancer patients

Effects of Bladder and Rectum Management on Dose Distributions of Target and Organs at Risk in Intensity-Modulated Radiotherapy for Prostate Cancer

SU-GG-T-598: Dose Calculation with MV CBCT Images for Head and Neck from a New Imaging Beam Line

Evaluation of magnetic resonance imaging derived synthetic computed tomography for proton therapy planning in prostate cancer